Equities
Basic MaterialsChemicals
  • Price (USD)74.26
  • Today's Change-0.48 / -0.64%
  • Shares traded3.16k
  • 1 Year change-19.07%
  • Beta1.0411
Data delayed at least 15 minutes, as of Jul 14 2025 20:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Arkema SA is a France-based chemical producer, which provides specialty chemicals and advanced materials. The Company manufactures a range of products for industries, including construction, packaging, chemical, automotive, electronics, food, and pharmaceutical industries. The Company operates through five business segments: Advanced materials that includes high performance polymers, specialty surfactants, molecular sieves, organic peroxides, oxygenates, and others; Adhesives that includes sealants, adhesives for floors and tiles, waterproofing products, and others; Coating solutions that include resins, emulsions for adhesives, surface coating products, absorbents, and others; Intermediate products that include thermoplastic polymers (PMMA) polymethyl methacrylate, acrylic products, fluorinated gases, and others. The Company has production centers located in Europe, North America and Asia. It operates through a network of subsidiaries, such as XL Brands.

  • Revenue in USD (TTM)11.20bn
  • Net income in USD360.02m
  • Incorporated2002
  • Employees21.15k
  • Location
    Arkema SA420 rue d'Estienne d'OrvesPUTEAUX 92800FranceFRA
  • Phone+33 149008080
  • Fax+33 149008396
  • Websitehttps://www.arkema.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Avient Corp3.24bn99.90m3.13bn9.20k31.601.3611.090.96711.081.0835.2025.170.55415.966.71351,956.501.732.101.982.4933.1330.453.123.621.512.570.47277.893.112.51123.6117.528.335.72
Hawkins Inc974.43m84.35m3.24bn1.04k38.516.9826.073.324.034.0346.5722.251.369.477.91941,479.3011.8110.8913.8612.9223.1520.358.667.431.3721.940.244319.526.0112.5211.9224.3510.858.70
Scotts Miracle-Gro Co3.45bn36.10m4.00bn2.50k134.37--34.971.160.51580.515859.87-5.030.92613.084.121,381,880.000.96770.27441.340.36128.7828.211.040.25740.94361.961.132,053.020.03942.4090.82--14.653.43
Cabot Corp3.91bn428.00m4.21bn4.20k10.112.956.901.087.767.7670.8926.571.065.385.27930,476.2012.687.1116.8910.1724.8721.8711.986.461.3013.890.447741.791.603.66-14.4219.261.473.69
Sensient Technologies Corp1.56bn128.19m4.61bn4.01k35.964.2124.422.953.023.0236.8825.790.76371.805.10389,856.306.266.277.037.1932.9332.708.198.201.746.960.390657.956.923.3133.488.738.652.21
Balchem Corp964.54m136.54m5.17bn1.38k38.024.2728.425.364.174.1729.4437.060.60174.877.14708,702.408.527.529.288.3035.5532.0714.1612.111.4013.380.13722.283.398.1818.3610.034.6510.84
FMC Corp4.12bn383.00m5.29bn5.70k13.871.219.461.293.062.6132.8935.080.34651.681.44722,719.303.247.394.5710.5839.4741.419.3616.691.122.670.475833.23-5.36-1.63-71.66-5.72-13.717.18
Arkema SA - ADR11.20bn360.02m5.67bn21.15k15.62--4.320.50604.794.79148.86--0.65165.556.45531,385.802.22--2.69--19.95--3.41--1.648.380.3362--0.3153---15.92------
Element Solutions Inc2.48bn284.60m5.99bn5.30k21.052.3813.612.421.171.1810.2010.390.51014.875.42467,094.305.873.436.343.7142.0640.1411.517.123.165.870.390537.525.306.00109.1425.1918.16--
Axalta Coating Systems Ltd5.24bn449.00m6.67bn12.90k14.943.219.101.272.042.0423.859.500.72334.484.86409,687.506.223.467.684.2734.3632.108.605.271.534.230.6170.001.773.3146.229.444.47--
Celanese Corp10.06bn-1.65bn6.68bn12.16k--1.29--0.6639-15.10-15.2291.8847.400.40863.347.95826,934.10-6.676.85-8.088.4622.6525.09-16.3313.971.112.540.694824.03-6.0310.30-176.89--3.293.13
Newmarket Corp2.79bn478.87m6.85bn2.06k14.444.5111.412.4650.3050.30292.81161.060.87343.836.011,354,742.0015.0413.5917.1616.6832.4627.2817.2212.621.6011.620.394627.373.274.9318.9012.66-0.72216.50
Albemarle Corp5.09bn-1.31bn8.35bn8.30k--1.07--1.64-11.12-11.1243.3385.240.28272.766.59613,695.30-9.450.6312-10.800.77533.5322.05-33.411.501.26-2.310.256226.36-44.088.42-183.64--14.632.29
Data as of Jul 14 2025. Currency figures normalised to Arkema SA's reporting currency: US Dollar USD

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
FCA Corp.as of 31 May 20253.13k0.00%
RhumbLine Advisers LPas of 31 Mar 2025546.000.00%
GAMMA Investing LLCas of 31 Mar 202524.000.00%
PNC Investments LLCas of 31 Mar 202520.000.00%
Cambria Investment Management LPas of 02 Jul 20257.000.00%
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.